Imaging biomarkers of NAFLD, NASH, and fibrosis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non-alcoholic steatohepatitis (NASH). Liver biopsy is invasive, subject to sampling and interobserver variability, and impracti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajmera, Veeral, Loomba, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324681/
https://www.ncbi.nlm.nih.gov/pubmed/33460786
http://dx.doi.org/10.1016/j.molmet.2021.101167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324681/
https://www.ncbi.nlm.nih.gov/pubmed/33460786
http://dx.doi.org/10.1016/j.molmet.2021.101167

Ejemplares similares